Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Drug makers raise prices in face of healthcare reform

New York Times, November 16, 2009

In the last year, the drug industry has raised the wholesale prices of brand-name prescription drugs by about 9%, according to industry analysts. That will add more than $10 billion to the nation's drug bill, which is on track to exceed $300 billion this year. Drug makers say they have valid business reasons for the price increases, but critics say the industry is trying to establish a higher price base before Congress passes legislation that tries to curb drug spending in coming years.